中医传承辅助平台分析张伟教授治疗慢性阻塞性肺疾病的用药规律

详细信息    查看全文 | 推荐本文 |

英文篇名：Systematic Analysis of Professor ZHANG Wei's Medication Rules for Chronic Obstructive Pulmonary Disease Based on Traditional Chinese Medicine Inheritance Support System 作者：洪丹东 ; 江双凤 ; 张伟 英文作者：HONG Dan-dong;JIANG Shuang-feng;ZHANG Wei;Guangzhou University of Traditional Chinese Medicine;The First Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine; 关键词：慢性阻塞性肺病 ; 中医传承辅助平台 ; 用药规律 英文关键词：chronic obstructive pulmonary disease;;traditional Chinese medicine(TCM) inheritance support system;;formula application 中文刊名：HNZB 英文刊名：Guiding Journal of Traditional Chinese Medicine and Pharmacy 机构：广州中医药大学;广州中医药大学第一附属医院; 出版日期：2018-10-30 出版单位：中医药导报 年：2018 期：v.24;No.318 基金：广东省省级科技计划项目(2013A032500012) 语种：中文; 页：HNZB201820019 页数：4 CN：20 ISSN：43-1446/R 分类号：66-68+74

摘要

目的:基于中医传承辅助平台软件,分析总结张伟教授治疗慢性阻塞性肺疾病(COPD)的组方及用药规律。方法:应用中医传承辅助平台软件(V1.1),通过构建中医药治疗COPD的方剂数据库,采用软件集成的数据挖掘方法,对85首治疗COPD的方剂进行用药频次、组方规律及新方分析。结果:在研究的85首处方中,确定了处方中各种药物的使用频次,药物之间的关联规则,演化得到核心组合14个、新处方7个。结论:张伟教授治疗慢性阻塞性肺疾病的主要治则为健脾化痰、补肺活血、化痰止咳。
        Objective:Through traditional Chinese medicine(TCM) inheritance support system(V1.1),the prescription and medication rules of Professor ZHANG Wei in the treatment of chronic obstructive pulmonary disease were analyzed and summarized.Methods:The TCM inheritance support system(V1.1) was adopted to construct the traditional Chinese Medicine Inheritance Assistant Platform.Based on the software integration of data mining methods,85 prescriptions for the treatment of COPD were analysised by medication frequency,composition rules and new prescriptions.Results:Based on the analysis of 85 cases of prescriptions,the frequency of each herbs and association rules were computed in the database,and 14 core combinations and 7 new prescriptions were explored from the database.Conclusion:The characteristics of Professor ZHANG Wei's treatment of COPD were strengthening the spleen and reducing phlegm,tonifying lung and promoting blood circulation,and preventing phlegm and stopping cough.

引文

[1]El-Zein R A,Young R P,Hopkins R J,et al.Genetic predisposition to chronic obstructive pulmonary disease and/or lung cancer:important considerations when evaluating risk[J].Cancer Prev Res,2012,5(4):522-527.
    [2]兰丰铃,王胜锋,曹卫华,等.慢性阻塞性肺疾病危险因素流行病学研究新进展[J].中华疾病控制杂志,2014,18(10):998-1002.
    [3]王光磊,张春兆.慢阻肺稳定方治疗慢阻肺稳定期的疗效观察[J].光明中医,2017,32(14):2004-2005.
    [4]王东,刘江.益肺健脾颗粒改善老年慢阻肺患者肺功能及免疫功能[J].世界中医药,2016,11(12):2634-2636,2640.
    [5]王冬梅.中医治疗稳定期慢阻肺的临床研究[J].中医临床研究,2016,8(18):33-34.
    [6]彭磊,范毕辉,陆剑豪.慢阻肺稳定方治疗慢性阻塞性肺疾病稳定期疗效观察[J].现代中西医结合杂志,2014,23(3):303-304,342.
    [7]沈楚婕,张伟.水通道蛋白在肺部疾病诊断治疗中的研究进展[J].实用医学杂志,2015(15):2415-2417.
    [8]董洪珍,张伟,郑洋.五脏相关理论之肺脾相关理论的实验研究总结和探讨[J].辽宁中医杂志,2016,43(2):274-275.
    [9]张伟,肖惠珍,苗倩.强肌健力方对肺脾两虚型COPD大鼠气道壁厚度和转移生长因子β1的影响[J].辽宁中医杂志,2009,36(4):638-640.
    [10]张伟,宫静,张靖轩,等.一种肺脾两虚型慢阻肺动物模型的建立[J].辽宁中医杂志,2009,36(1):142-143.
    [11]刘小虹,廖慧丽,张伟,等.肺康颗粒对缺氧大鼠肺动脉高压血管内皮损伤的保护作用[J].中成药,2003,25(9):55-57.
    [12]张伟,刘小虹,刘建博,等.肺康颗粒对缺氧性疲劳膈肌张力及耐力的影响[J].广州中医药大学学报,2004,21(06):457-459.
    [13]赖乾,李娟,李金田,等.基于中医传承辅助平台的中医药治疗慢性阻塞性肺疾病的用药规律分析[J].中国老年学杂志,2017,37(16):4019-4021.
    [14]庄贺,赵艳青,侯王君,等.基于中医传承辅助平台的慢性阻塞性肺病治疗方剂组[J].时珍国医国药,2016,27(7):1785-1787.
    [15]周仲瑛.中医内科学[M].北京:中国中医药出版社,2007:112.